================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
May 8, 2003
Date of Report (Date of earliest event reported)
------------------
ZymoGenetics, Inc.
(Exact name of registrant as specified in its charter)
Washington 0-33489 91-1144498
(State or other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
1201 Eastlake Avenue East
Seattle, Washington 98102-3702
(Address of principal executive offices) (Zip Code)
206-442-6600
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Item 7. Financial Statements, Pro Forma Financial Information And Exhibits.
(c) Exhibits.
Exhibit 99.1 - Press Release dated May 8, 2003 of ZymoGenetics, Inc.
Item 9. Regulation FD Disclosure
In accordance with the interim guidance of the Securities and Exchange
Commission set forth in SEC Release No. 33-8216, ZymoGenetics, Inc. (the
"Registrant") is furnishing the information required by Item 12 of Form 8-K
under "Item 9 Regulation FD Disclosure" and information contained in this report
(including exhibits hereto) shall not be deemed filed under the Securities and
Exchange Commission's rules and regulations and shall not be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended.
On May 8, 2003, the Registrant issued a press release announcing its
results of operations and financial condition for the three months ended March
31, 2003. The full text of the press release is set forth in Exhibit 99.1
attached hereto. The press release should be read in conjunction with the note
regarding forward-looking statements, which is included in the text of the press
release.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
ZYMOGENETICS, INC.
Date: May 8, 2003 By: /s/ JAMES A. JOHNSON
-------------------------------
Name: James A. Johnson
Title: Senior Vice President, and
Chief Financial Officer
3
EXHIBIT INDEX
Exhibit
Number Document Description
- ------- --------------------
99.1 Press release dated May 8, 2003 of ZymoGenetics, Inc.
4